Name: UMIN ID:
Unique ID issued by UMIN | UMIN000026498 |
---|---|
Receipt number | R000030430 |
Scientific Title | Evaluation of efficacy and safety of a response adapted therapy adding bortezomib in newly diagnosed, transplant ineligible multiple myeloma patients with insufficient efficacy by lenalidomide - dexamethasone (Rd) therapy. |
Date of disclosure of the study information | 2017/03/10 |
Last modified on | 2021/03/13 16:01:47 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2017/03/10 13:11:51 | ||
2 | Update | 2017/06/02 11:51:53 | Recruitment status Date of protocol fixation Anticipated trial start date |
|
3 | Update | 2019/09/11 11:02:06 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Address Last name of contact person Last name of contact person Zip code Address Organization Organization Address Address Tel |
|
4 | Update | 2021/03/13 16:01:47 | Recruitment status Date of IRB Last follow-up date |